(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Ennaid's Harrison on Developing Cure for the Zika Virus (Audio)

Matt Miller and Paul Sweeney focus on market coverage as Wall Street begins its day, with analysis from Bloomberg Opinion writers, Bloomberg Intelligence analysts, and influential newsmakers.

Share Ennaid's Harrison on Developing Cure for the Zika Virus (Audio)

Sign up to save your podcasts

Ennaid's Harrison on Developing Cure for the Zika Virus (Audio)

Ennaid's Harrison on Developing Cure for the Zika Virus (Audio)